Clinical Trials Browser

Suspended × spartalizumab × Clear all

NCT07403136 2026-04-15

Vebrekotuzumab ± Anti-PD-1 in Pretreated Advanced ESCC

Phase 2 Suspended

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06728657 2025-06-18

TORCH-G

Phase 2 Suspended

Gastrointestinal

Stomach Adenocarcinoma

NCT03779100 2019-01-28

Lenvatinib Plus PD-1 Antibody for Unresectable ICC

Phase 2 Suspended

Gastrointestinal

Cholangiocarcinoma